Table III.

Correlations between preoperative serum sMR and sCD163 levels with major clinical variables.

	Serum sMR (µg/ml)			Serum sCD163 (µg/ml)
Variables	Low (n=55)	High (n=88)	P	Low (n=66)	High (n=77)	P-value
Age, years			0.628			0.243
<60	16	29		24	21
≥60	39	59		42	56
Sex			0.221			0.523
Male	41	57		47	51
Female	14	31		19	26
Tumor size, cm			0.628			0.085
≤5	39	59		50	48
>5	16	29		16	29
Differentiation			0.714			0.011
Well/Moderate	29	37		38	28
Poor	26	51		28	49
T stage			0.004			<0.001
T1+T2	23	17		31	9
T3+T4	32	71		35	68
N stage			0.022			<0.001
N0	26	25		42	9
N1-N3	29	63		24	68
M stage			0.034			0.003
M0	53	75		65	63
M1	2	13		1	14
Clinical stage			0.003			<0.001
I+II	34	32		51	15
III+IV	21	56		15	62
CEA			0.001			0.020
Negative	48	55		55	58
Positive	7	33		11	29
CA199			0.016			0.023
Negative	51	68		60	59
Positive	4	20		6	18
CA125			0.078			0.191
Negative	54	78		63	69
Positive	1	10		3	8
CA724			0.663			0.363
Negative	40	61		51	50
Positive	15	27		15	27
Vital status			0.010			0.001
No	46	56		56	46
Yes	9	32		10	31